Summer Sale

50% off Premium Yearly

00days
00hrs
00mins
00secs
HMP.TO 0.03SPGP 1ZUQ.TO 0.55NVDA 0.32GL 1.66MRK -1.71IEMG 0.5GEV 33.87
Daily Stock Opinions and Ratings
Stockchase Opinions

Peter HodsonID BiomedicalIDB.TOBUY ON WEAKNESSJul 29, 2003

Developing a flu vaccine. Well cashed up. Would buy it, but at a lower level.
Peter HodsonPeter Hodson
No
Unlock Rating
$17.54

Stock price when the opinion was issued

biotechnologypharmaceutical
It's the ideal tool to help you make quicker, more informed decisions for managing and tracking your investments.
Get Signals Create your Watchlist

You might be interested:

HOLD

ID Biomedical(IDB.TO)

Sep 20, 2005
GlaxcoSmithKline (GSK-N) is taking the company over. Speculation is that someone else will come in with a better offer. Can't see much risk in holding on to your shares.
Photo of Norman LevineNorman LevineUnlock Rating
$34.90

Stock price when the opinion was issued

biotechnologypharmaceutical
BUY

ID Biomedical(IDB.TO)

May 09, 2005
Have a large vaccine contract in the US. Should have a large increase in earnings and the stock should have a lot of upside.
Photo of Jean-Francois TardifJean-Francois Tardif
Owned
Unlock Rating
$21.50

Stock price when the opinion was issued

biotechnologypharmaceutical
DON'T BUY

ID Biomedical(IDB.TO)

Dec 03, 2004
Biotech stocks are very risky. This one has done very well on the flu vaccine problem in the US. A low margin business. Very expensive.
Photo of Jean-Francois TardifJean-Francois Tardif
No
Unlock Rating
$20.05

Stock price when the opinion was issued

biotechnologypharmaceutical
BUY

ID Biomedical(IDB.TO)

Aug 23, 2004
The pharmaceutical sector has been torn apart. This company that has done a very good job in managing and developing some products.
Photo of Robert FloydRobert Floyd
Owned
Unlock Rating
$14.64

Stock price when the opinion was issued

biotechnologypharmaceutical
BUY ON WEAKNESS

ID Biomedical(IDB.TO)

Sep 22, 2003
Likes the story. Has had a pretty good run, but has more room to go. Very strong news out of the company. Some trial results still to come out in the next little while.
Photo of Robert FloydRobert FloydUnlock Rating
$25.47

Stock price when the opinion was issued

biotechnologypharmaceutical
BUY

ID Biomedical(IDB.TO)

Mar 03, 2003
Good product. In final phases of testing.
Photo of Robert FloydRobert FloydUnlock Rating
$8.16

Stock price when the opinion was issued

biotechnologypharmaceutical
WEAK BUY

ID Biomedical(IDB.TO)

Feb 04, 2003
Very volatile. Well managed and has a lot of cash.
Photo of Peter HodsonPeter HodsonUnlock Rating
$10.06

Stock price when the opinion was issued

biotechnologypharmaceutical
BUY

ID Biomedical(IDB.TO)

Jan 15, 2003
Still has substantial upside. Into some interesting products.
Photo of Robert FloydRobert FloydUnlock Rating
$11.45

Stock price when the opinion was issued

biotechnologypharmaceutical
PAST TOP PICK

ID Biomedical(IDB.TO)

Apr 05, 2002
(Was a top pick on Dec 21 up 50%) Can still go higher.
Photo of Robert FloydRobert FloydUnlock Rating
$9.61

Stock price when the opinion was issued

biotechnologypharmaceutical
TOP PICK

ID Biomedical(IDB.TO)

Dec 21, 2001
Well capitalized. Strong management.
Photo of Robert FloydRobert FloydUnlock Rating
$6.64

Stock price when the opinion was issued

biotechnologypharmaceutical
TOP PICK

ID Biomedical(IDB.TO)

Jul 09, 2001
Photo of Robert FloydRobert FloydUnlock Rating
$5.15

Stock price when the opinion was issued

biotechnologypharmaceutical
TOP PICK

ID Biomedical(IDB.TO)

Jun 14, 2001
Strong cash position. Good mngmnt. Good outlook.
Photo of Robert FloydRobert FloydUnlock Rating
$6.40

Stock price when the opinion was issued

biotechnologypharmaceutical
TOP PICK

ID Biomedical(IDB.TO)

May 14, 2001
Well capitalized. Good product line.
Photo of Robert FloydRobert FloydUnlock Rating
$5.95

Stock price when the opinion was issued

biotechnologypharmaceutical
TOP PICK

ID Biomedical(IDB.TO)

Mar 28, 2001
New acquisition is a good fit. Strong cash positions.
Photo of Robert FloydRobert FloydUnlock Rating
$4.81

Stock price when the opinion was issued

biotechnologypharmaceutical
The ultimate 360° Tracker Your financial life in one place, automatically

Build your watch list

Sign in to track investments
you care about

Latest Buy Signals

EPD -0.03$37.25
ET 0.31$19.07
MAIR 0$
RKLB -12.39$102.39
SESG-O 0$

Today's Top Picks

HMP.TO 0.03$9.75
SPGP 1$120.39
ZUQ.TO 0.55$107.47
NVDA 0.32$205.19
GL 1.66$166.76

Popular Articles

Latest Sell Signals

PRGO 0.09$10.99
CBRS 0$
HAWK 0$
AVEX 0$
SWMR 0$

Most Recent Experts

Jim Cramer - Mad Money

Jim Cramer - Mad Money

CNBC

Richard Orrell

Richard Orrell

RN Croft Financial Group

Stockchase Insights

Stockchase Insights

5i Research

The Panic-Proof Portfolio (Stockchase Research)

The Panic-Proof Portfolio (Stockchase Research)

Stockchase Premium

Stan Wong

Stan Wong

Private Wealth Management, ScotiaMcleod

disclaimer

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at: [email protected].

About usHow to useContact Us
More...
AdvertisingIn the newsPrivacy PolicyTerms of service
FacebookX
© 2000 - 2026 Stockchase Inc. by Wealthica